VIVIMED LABS LIMITED (VIVIMEDLAB)

NSE: ₹6.43
BSE: ₹6.62
Stock Performance
Corporate Announcements
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

form G

2026-06-17 13:32:06
Board Meeting Postponed

Board meeting Postponed

2026-05-30 15:17:08
Update on board meeting

The Board Meeting to be held on 28/05/2026 has been revised to 30/05/2026

2026-05-26 18:09:30
Compliances-Reg.24(A)-Annual Secretarial Compliance

annual secretarial compliance report

2026-05-19 19:46:35
Board Meeting Intimation for Audited Results

audited results for FY 2025-2026

2026-05-17 13:56:23
Corporate Insolvency Resolution Process (CIRP)-Public Announcement

Form A - Public Announcement

2026-04-23 13:14:21
Admission To CIRP

ADMISSION TO CIRP

2026-04-17 16:03:04
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

certificate under reg 74(5)

2026-04-08 16:34:53
Initial Disclosure

Initial disclosure- Not Large corporate

2026-04-06 15:11:14
Closure of Trading Window

CLOSURE OF TRADING WINDOW

2026-04-02 11:21:27

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 35.35 33.64 41.46 38.62 29.37 24.77 36.51 25.61 21.39 20.61 15.99 12.00
YOY Revenue Growth % -29.45% -23.93% -25.62% 4.28% -16.91% -26.37% -11.94% -33.67% -27.18% -16.79% -56.21% -53.15%
Other Income 0.11 2.20 0.04 7.62 0.06 0.03 0.07 4.22 0.38 0.21 0.00 5.75
Total Income 35.46 35.84 41.50 46.24 29.43 24.80 36.58 29.83 21.77 20.82 15.99 17.75
Total Expenses + 51.04 56.14 58.10 39.59 44.68 29.94 42.55 34.84 27.26 28.13 32.54 163.65
Cost of Materials Consumed 17.47 17.36 20.83 33.89 19.82 15.47 14.71 7.76 10.77 5.30 8.93 7.91
Employee Benefit Expense 7.63 9.78 9.75 6.99 6.03 6.29 7.29 8.79 5.71 5.60 3.70 9.97
Other Expenses 9.97 12.02 8.67 46.21 16.99 7.76 8.47 7.38 6.17 6.85 15.32 94.29
Operating Profit -15.69 -22.50 -16.64 -0.97 -15.31 -5.17 -6.04 -9.23 -5.87 -7.51 -16.55 -151.65
OPM % -44.4% -66.9% -40.1% -2.5% -52.1% -20.9% -16.5% -36% -27.4% -36.5% -103.5% -1263.7%
Profit Before Tax + -15.58 -20.30 -16.60 6.65 -15.25 -5.14 -5.98 -5.01 -5.49 -7.30 -16.55 -145.90
Tax Expense 0.00 0.00 -0.55 1.39 0.00 0.00 0.00 -5.01 0.00 0.00 0.00 0.14
Tax % - - - 20.9% - - - - - - - -
Profit After Tax -15.58 -20.30 -16.05 5.26 -15.25 -5.14 -5.98 0.00 -5.49 -7.30 -16.55 -146.04
EPS (Basic) 1.88 -2.45 -1.24 0.64 -1.84 -0.60 -0.72 -0.67 -0.66 -0.88 -0.88 -17.74

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 69.99 116.27 149.07 187.10 237.29 861.47 1,058.80
YOY Revenue Growth % -39.8% -22% -20.33% -21.15% -72.46% -18.64% -
Other Income 6.32 4.37 9.98 0.97 1.27 9.82 8.26
Total Income 76.31 120.64 159.05 188.07 238.56 871.29 1,067.05
Total Expenses + 251.56 152.03 204.87 518.72 303.39 947.06 1,176.53
Cost of Materials Consumed 32.91 57.76 89.55 109.95 153.00 356.56 483.24
Employee Benefit Expense 24.97 28.39 34.16 32.67 36.22 195.66 233.36
Other Expenses 122.62 40.61 76.87 70.23 55.64 287.50 354.78
Operating Profit -181.57 -35.76 -55.80 -331.62 -66.10 -85.59 -117.73
OPM % -259.4% -30.8% -37.4% -177.2% -27.9% -9.9% -11.1%
Profit Before Exceptional -175.25 0.00 -45.82 -330.65 -64.83 -75.77 -109.47
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + -175.25 -31.39 -45.82 -330.65 -64.83 -75.77 -109.47
Tax Expense 0.14 -31.39 -0.38 -2.12 2.82 2.03 -0.36
Tax % - - - - - - -
Profit After Tax -175.38 0.00 -45.45 -328.53 -67.65 -77.80 -109.12
EPS (Basic) -21.15 -3.85 -5.48 -39.62 -8.16 -18.76 -13.16

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 585.48 593.28 608.33 656.06 758.75 760.62 1,234.34
Property, Plant & Equipment 237.01 254.40 262.86 278.18 362.57 348.13 698.20
Capital Work in Progress 17.79 0.00 20.65 20.67 40.03 60.12 89.28
Non-Current Investments 180.54 168.50 0.00 0.00 0.00 0.00 0.00
Goodwill 6.87 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 141.74 0.00 155.07 0.00 0.00 0.00 0.00
Current Assets + 168.00 327.56 342.58 332.29 507.27 528.71 975.28
Inventories 12.72 58.76 64.06 79.76 240.77 255.68 501.91
Trade Receivables 45.33 0.00 82.82 76.81 87.36 107.50 249.07
Cash and Cash Equivalents 0.07 0.71 2.03 3.76 7.18 6.43 50.49
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity -210.55 0.00 -5.46 39.42 364.29 431.58 834.59
Equity Share Capital 16.58 0.00 16.58 16.58 16.58 16.58 16.58
Other Equity -227.14 0.00 -22.04 22.84 347.70 414.99 492.79
Non-Current Liabilities 515.92 547.81 546.05 524.62 527.97 516.31 604.67
Current Liabilities 448.11 408.20 410.33 424.30 373.76 341.44 770.36
Total Liabilities 964.03 0.00 956.37 948.92 901.73 857.75 1,375.03

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 7.70 -10.81 -23.99 13.81 -658.47 567.28 0.00
Cash from Investing Activities -0.95 4.53 28.29 -0.99 523.34 404.00 0.00
Cash from Financing Activities -6.11 4.96 -6.03 -16.24 -10.38 -1,015.33 0.00
Net Increase/Decrease in Cash 0.65 -1.32 -1.74 -3.42 -139.08 -44.06 0.00